A bank of 892 human autoimmune serum samples was screened by indirect immunofluorescence on human tissue culture cells. Seven serum samples that stain 4 to 10 bright dots in cell lines of several different mammals, including humans, monkeys, rats, and pigs, were identified. Immunofluorescence experiments indicate that these antigens, called nuclear dot (ND) antigens, are distinct from splicing complexes, kinetochores, and other known nuclear structures. An ND antigen recognized by these sera was cloned by immunoscreening a human Agtll expression libraxy. Analysis of seven cDNA clones for the ND antigen indicates that several mRNAs exist, perhaps derived through alternative splicing mechanisms. One major form of the message has an open reading frame of 1,440 bp capable of encoding a 53,000-Mr protein. Treatment of cells with detergent, salt, or RNase A fails to remove the ND antigen from the nucleus. However, incubation with DNase I obliterates ND staining, indicating that the ND protein directly or indirectly associates with nuclear DNA. Fusion of the ND protein to a LexA DNA binding domain activates transcription in Saccharomyces cerevisiae. A 75-amino-acid domain that activates transcription in both yeast and primate cells has been identified. We suggest that ND antigens may participate in the activation of transcription of specific regions of the genome. * Corresponding author. t Present address: Gilman Laboratory, Department of Biological Science, Dartmouth College, Hanover, NH 03755.
A wide variety of cellular processes occur within the nucleus, including DNA replication, RNA transcription and processing, and ribosome biogenesis (18, 33) . Some of these activities are carried out in distinct regions of the nucleus; ribosome biogenesis occurs within the nucleolus (13) , splicing complexes are organized into splicing domains (14, 17) , and DNA replication occurs at discrete sites (15) . Other less well-characterized regions of the nucleus have also been described, including nuclear bodies, which appear as granular fibrils defining the space between perichromatin and perinuclear chromatin (7, 52) , and polymorphic interphase karyosomal associations, which appear as nuclear domains that are very heterogeneous in size and number from one cell to the next (42) . To what extent other morphological domains exist in the nucleus and whether they carry out distinct cellular functions are not known.
One method to determine whether specific subcellular domains exist within the mammalian nucleus is to screen sera from autoimmune disease patients for antibodies that recognize novel staining patterns. Patients with specific autoimmune diseases often contain antibodies directed to nuclear components (10, 27, 51) . These include antibodies directed to kinetochores (5, 12, 20, 32) , nuclear lamins (24, 37) , topoisomerase I (29) , proliferating-cell nuclear antigen (4, 28, 36) , and splicing components (26, 34, 38) . One unusual type of autoantibody recognizes speckled dots or nuclear dots (NDs) (2, 6, 39) , which are visible as approximately six brightly staining dots in the nucleus.
In this report, we describe autoantibodies directed to a 72,000-Mr ND antigen. The ND domain is distinct from known nuclear domains such as splicing centers or kinetochores. Cloning and molecular characterization of a major ND antigen are also reported. In the course of our studies, ND ANTIGENS MAY SPECIFY TRANSCRIPTIONAL DOMAINS 6171 produced a fusion protein with a predicted Mr of 62,000. The TrpE-ND protein was overexpressed in Escherichia coli RR1 (3, 35) as previously described (45, 46) . The fusion protein was excised from a preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel and electroeluted. The purified protein was used to immunize a rabbit (Pocono Rabbit Farm). A total of 200 mg of purified fusion protein was used for the initial injection, and 100 mg was used for subsequent boosts. Injections were spaced 2 weeks apart. Both preimmune and immune sera were tested for their immunoreactivity by performing double indirect immunofluorescence and immunoblot analyses. Antibodies that recognize the TrpE-ND fusion protein were affinity purified as described by Snyder (46) .
Preparation of HeLa nuclei. HeLa nuclei were prepared as described by Cooke et al. (9) . Approximately 108 confluent cells were rinsed with phosphate-buffered saline (PBS) (150 mM NaCl, Na phosphate, pH 7.4) containing 10 mM EDTA and harvested with a plastic policeman (Costar Corp.). Cells were pelleted and resuspended in 40 ml of 10 mM Tris-HCl (pH 7.4)-10 mM NaCl-5 mM MgCl2. This solution and all others described below contained the following proteinase inhibitors: 10 ,ug of pepstatin A per ml (Sigma), 10 jig of chymostatin per ml (Sigma), 10 ,ug of leupeptin per ml (Sigma), 2 ,ug of aprotinin per ml (Sigma), and 0.1 mM phenylmethylsulfonyl fluoride (Sigma). Cells were swollen for 5 min and centrifuged at 900 x g for 3 min. The pelleted cells were then resuspended in .4], 0.375 mM spermidine) was then added to a total volume of 40 ml, and the nuclei were centrifuged for 10 mi at 1,000 x g. Nuclei were washed once with buffer 3 and centrifuged for 10 min at 1,000 x g. Purified nuclei were resuspended in 1 ml of 5 mM Tris-HCl, (pH 7.4)-2 mM KCl-0.375 mM spermidine. Samples were denatured in SDS sample buffer (23) for immunoblotting analysis. In situ cell fractionation assay. In situ cell fractionation assay was carried out essentially as described by Staufenbiel and Deppert (49) . HeLa cells were grown on coverslips to near confluency. The cells were washed with ice-cold Kern Matrix (KM) buffer (10 mM N-morpholino-ethanesulfonic acid [pH 6.2], 10 mM NaCl, 1.5 mM MgCl2, 10% glycerol, and the proteinase inhibitors as described above). The cells were first extracted with KM buffer containing 1% Nonidet P-40 (NP-40), 1 mM EGTA [ethylene glycol-bis(,B-aminoethyl ether)-N,N,N',N'-tetraacetic acid], and 5 mM dithiothreitol. Cells were then treated with (i) DNase I or RNase A (50 ,g/ml in KM buffer) at 37°C for 30 min or (ii) KM buffer containing 1 mM EGTA and 5 mM dithiothreitol and either 0.25 M (NH4)2SO4 or different concentrations of NaCl (0.5, 1.0, 1.5, and 2.0 M) and incubated on ice for 30 min. Extracted cells were washed with KM buffer and fixed with 1% formaldehyde in PBS. The fixed cells were then processed for indirect immunofluorescence with affinity-purified rabbit anti-ND antibodies and stained with Hoechst 33258.
Immunoblots. Nuclear proteins were separated in a 12% polyacrylamide gel containing 0.1% SDS (23) and subsequently transferred to nitrocellulose (22) with a semidry protein transfer apparatus (Hoefer). The position of the marker proteins was determined by staining with 0.2% Ponceau S. Filters were blocked overnight with Tris-buff-ered saline (TBS) (150 mM NaCl, 50 mM Tris-HCl [pH 8.0]) containing 20% fetal calf serum and 5% nonfat dry milk. Blocked filters were incubated with primary antibodies diluted 1:500 to 1:1,000 in TBS plus 20% fetal calf serum for 12 h or longer at 4°C. Filters were then washed once with TBS containing 0.1% bovine serum albumin (BSA), twice with TBS plus 0.1% BSA and 0.1% NP-40, and once with TBS containing 0.1% BSA. Washed filters were incubated with 0.5 ,Ci of 1"I-protein A per ml (>30 mCi/mg; ICN) in TBS containing 0.1% BSA at room temperature for at least 2 h and washed as described above. Filters were finally air dried and exposed to X-ray films with an intensifying screen at -700C. Yeast j8-galactosidase (P-Gal) assays. The full-length or truncated ND protein coding fragments (see Fig. 6 ) were amplified by polymerase chain reaction (41) with 25-to 35-bp primers which contained EcoRI recognition sequences at their 5' ends. The amplified fragments were cleaved with EcoRI and ligated into EcoRI-cleaved plasmid vector pSH2-1 (16) . Proper orientation was determined by restriction mapping analysis. These constructs fuse ND sequences in frame to coding sequences of the LexA DNA binding domain (amino acids 1 to 87); the hybrid proteins are expressed from the ADHI promoter, and an ADHI terminator lies downstream of the expressed gene. The constructs were transformed into yeast strain CJIY10-5D (8) , which contains a LexA protein binding site upstream of a lacZ gene. For each yeast transformant, the integrity of the fusion construct was verified by plasmid rescue in bacteria and restriction mapping analysis and then by subsequent sequencing analysis of the LexA-ND fusion junction region.
For the plate color assay, transformed yeast cells were grown as patches on a SC-His plate at 30°C (43) . MgSO4 in 1.6% agar with 120 p,g of X-Gal per ml). The X-Gal plate with the filter was incubated at 30°C until the patches appeared blue.
For quantitative ,-Gal assays, cells were grown in 5 ml of SC-His until the optical density at 600 nm = 1. Equal numbers of cells (-3 x 107) were pelleted and resuspended in 600 ,1u of Z buffer (8.4 g of Na2HPO4, 5.5 g of NaH2PO4, 0.8 g of KCI, and 0.2 g of MgSO4 per liter of water). A total of 10 ,ul of Zymolyase (10 mg/ml) was added, and the cells were incubated at 30°C until spheroplasted. Then, 5 PI of 2.5% SDS and 10 pl of 100 mM phenylmethylsulfonyl fluoride were added, and the tube was vortexed vigorously for 10 s. After 10 min at 28°C, the tubes were vortexed for 2 min and briefly spun to pellet the insoluble material. The reaction mixtures for the n-Gal assay were assembled in a 2-ml Eppendorf tube with 200 PI of o-nitrophenyl-f3-Dgalactopyranoside (ONPG) (4 mg/ml), 200 pl of extract, and 800 pl of Z buffer. The reaction mixtures were incubated at 28°C for 20 h, and 0.5 ml of 1 M Na2CO3 was added to stop the reaction. The tubes were then spun at 15,000 rpm for 15 min, and the optical density at 420 nm was read.
DNA transfection and CAT assay. Full-length and mapped ND transcription activation domains (residues 333 to 407) were amplified by polymerase chain reaction with 25-to 35-bp primers which contained EcoRI recognition sequences at both of their 5' and 3' ends. The fragments were digested with EcoRI and cloned into effector plasmid vector pSG424.
XIE ET AL.
Cotransfections of pSG424 construct with reporter plasmid G5EC were performed by calcium phosphate coprecipitation according to the method of Vasavada et al. (53) . The transfected CV1 cells were incubated for 6 h and shocked with 15% glycerol in Dulbecco's modified Eagle's medium without fetal calf serum and antibiotics. After 60 h of incubation, cells were collected with a plastic policeman. Cells were then subjected to three cycles of freezing and thawing, and cell debris was removed by centrifugation. The optical density at 600 nm was measured for each sample, and the volume of the extract used in the chloramphenicol acetyltransferase (CAT) assay was adjusted to reflect an equal amount of total protein in the samples. CAT assays were carried out as described by Vasavada et al. (53) .
RESULTS

Identification of autoantibodies that recognize ND antigens.
To search for autoantibodies that recognize subcellular structures of interest, 892 serum samples from autoimmune disease patients were screened by indirect immunofluorescence on a human adenocarcinoma-derived HT-29 cell line (56, 57) . Seven serum samples that stained 4 to 10 bright dots in the nucleus were identified. One such serum sample, 312, is shown in Fig. 1A . All of the sera strongly react with the NDs; three serum samples also stain the entire nucleus very weakly. Each of these sera was found to recognize similar antigens in a wide variety of mammalian cell lines including epithelium-like HeLa cells, a primary human fibroblast cell line, African green monkey kidney CV1 cells, and porcine intestinal LLC-PK1 cells. The sera did not cross-react with antigens in S. cerevisiae cells as determined by indirect immunofluorescence.
The dots are present only in interphase cells and disappear during mitosis (an example of a mitotic cell is shown below in Fig. SB) . The cell lines used in our studies are aneuploid, and cells which contain nuclei that appear twice as large as normal cells are often present in the population. These large cells usually contain approximately twice as many dots as the other cells, indicating that the number of dots roughly correlates with the ploidy (data not shown). The position of the NDs in both normal-size and enlarged cells appears to be random.
The different human autoimmune sera were used to probe immunoblots of nuclear proteins isolated from human HeLa cells. The seven serum samples that stained NDs all recognized a protein band with an M, of 72,000 (see Fig. 2A , lane 3, for staining with serum 312). Ten control autoimmune serum samples not exhibiting anti-ND staining did not recognize the 72,000-Mr polypeptide (see Fig. 2A , lane 4, for one example), suggesting that this protein corresponds to the ND antigen. Additional evidence supporting this conclusion is presented below.
Cloning of the ND gene. In order to learn more about the function of the ND antigen, serum 312 was used to immunoscreen a human placental cDNA Xgtll expression library (47) . One cDNA clone, XND1, which contains a 0.7-kb insert, was identified. The antigen produced by XND1 was recognized by all seven of the anti-ND autoimmune serum samples tested (data not shown). Fusion proteins produced from XND1 were used to affinity purify antibodies from the autoimmune serum 312. The affinity-purified antibodies recognized the ND antigens in indirect immunofluorescence experiments using HeLa cells (data not shown).
To further test whether the XND1 clone encoded an antigen associated with the NDs, the XND1 insert was subcloned into the pATH11 E. coli expression vector (21) and the encoded protein was overproduced as a 62,000-Mr fusion protein, of which 35,500 in Mr is TrpE. The TrpE-ND1 fusion protein was purified, and polyclonal antibodies were generated in rabbits. Experiments to be presented elsewhere revealed that this serum recognized multiple epitopes on the ND antigen. Immunoblot analysis indicates that the anti-ND antibodies recognize a 72,000-Mr nuclear polypeptide similar in size to that recognized by the human autoimmune sera (Fig. 2A, lane 2) . No such band is recognized by preimmune serum (Fig. 2A, lane 1) .
Double indirect immunofluorescence experiments with the rabbit anti-ND antibodies and each of the seven ND autoimmune serum samples indicate that the cloned antigens colocalize with the nuclear autoimmune antigens (shown for serum 312 in Fig. 1C and D) . Thus, we conclude that XND1 encodes an ND antigen. During the course of our studies, Ascoli and Maul (2) reported the characterization of autoimmune sera with a staining pattern similar to that of the sera presented above. To determine whether our anti-ND serum was recognizing the same domain as that reported by Ascoli and Maul, double indirect immunofluorescence was performed with the anti-ND serum and a mouse monoclonal serum against the ND antigen (2). As shown in Fig. 3 , the antigens recognized by these sera colocalize, indicating that they recognize the same ND domain.
The ND antigens do not correspond to any previously identified nuclear structure. The NDs do not correspond to the nucleolus as evidenced by the phase-dark region of the nucleus or by double indirect immunofluorescence with a human antinucleolus antibody (56) and the rabbit polyclonal antiserum to the cloned ND antigen (data not shown).
To test whether the NDs might be located at a subset of kinetochores or in splicing domains, double indirect immunofluorescence was performed on HeLa cells with rabbit anti-ND antibodies and either human antikinetochore antibodies or anti-Sm antibodies. The anti-ND antigens do not colocalize with either antikinetochore antigens, which are present as approximately 50 dots per nucleus (Fig. 3) , or with the anti-Sm antibodies which recognize splicing domains (data not shown). Thus, the NDs do not appear to be associated with any previously identified structures, a result independently observed by Ascoli and Maul for their anti-ND antiserum (see Discussion).
The ND mRNA may be alternatively spliced. To isolate the entire coding region of the ND antigen gene, the insert from the XND1 clone was labelled and used as a hybridization probe to screen the Xgtll placental cDNA library. Six additional clones (XND2 through -7) that contain an ND coding sequence were identified; five clones encode the entire ND protein coding sequence (Fig. 4A) .
The different XND cDNA clones were analyzed extensively by restriction mapping, and the DNA sequence was determined from the various clones in order to predict the FIG. 3 . Double indirect immunofluorescence of HeLa cells with an anti-ND serum and with a mouse monoclonal anti-ND antibody or human antikinetochore antibodies. The top panels show the same cells stained with rabbit anti-ND antibodies (aND) and a mouse ND antibody (mAb; a gift from G. G. Maul). The dots colocalize. The bottom panels show cells stained with rabbit anti-ND antibodies (aND) and human antikinetochore antibodies (Kin). The dots do not colocalize. The anti-ND was detected by fluorescein, mouse monoclonal antibody was detected by Texas Red, and antikinetochore antibodies were detected by rhodamine.
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. The other two cDNA clones contain simple deviations from the 1,885-bp continuous sequence. One clone, XND2, lacks exactly 153 bp from the center of the open reading frame compared with XND3 thru XND7 (Fig. 4) . Codons 272 to 323 are affected (Fig. 4B) , but otherwise the reading frame is maintained and the sequence is identical to that of the other clones. The 3' boundary of the sequences missing in XND2 is similar to the 3' consensus splice site sequence (54) . Thus, it is likely that the ND mRNA is alternatively spliced and that the XND2 cDNA was derived from one form of ND mRNA and the other cDNAs were generated from a distinct form.
The other clone, XND1, is identical in sequence to XND3 through -7 except at its carboxy-terminal coding sequence (Fig. 4C) . A total of 132 bp of unique sequence is present starting at codon 475; this sequence maintains the open reading frame and is therefore capable of producing a larger protein. This sequence does not contain the consensus splice sequence at its 5' end, suggesting that it is not an unspliced form of the ND mRNA. Attempts to isolate additional clones containing this unique sequence from the human placental cDNA library were unsuccessful. Thus, these data suggest that there are at least three related messages derived from ND coding sequences.
The ND protein migrates at 72 kDa in SDS-polyacrylamide gels. The entire open reading frame of the ND cDNA is capable of encoding a 53-kDa protein. However, immunoblot analysis of HeLa nuclear proteins with either affinitypurified rabbit polyclonal serum or the human autoimmune serum 312 revealed that the ND protein migrates significantly more slowly (molecular size, -72 kDa) than expected in polyacrylamide gels containing SDS. Furthermore, Szostecki et al. (50) reported that this ND antigen migrated at 100 kDa as judged by immunoblot analysis of HeLa cell proteins and by in vitro transcription and translation of the ND gene.
To investigate these discrepancies further, we cloned the entire XND7 ND open reading frame sequence into the vector pGEX-2T. The ND protein was overexpressed as a glutathione-S-transferase (GST) fusion protein and treated with thrombin, which cuts the ND portion from the GST.
Both thrombin-treated and untreated GST-ND were analyzed in a polyacrylamide gel containing SDS. As shown in Fig. 2B, the of both cleaved and uncut GST-ND with affinity-purified anti-ND serum confirmed this interpretation (data not shown). We conclude that the ND protein migrates at 72 kDa in our gel systems. -The ND protein is associated with nuclear DNA. To further understand the role of the ND protein, we investigated the nature of its association with the nucleus by in situ cell fractionation assays (30, 49) . HeLa cells were grown on coverslips and treated with detergent, salt, DNase I, or RNase A. Cells were then fixed and stained with affinitypurified anti-ND antibodies. As shown in Fig. 5 , the ND protein was still present in cells treated with (i) 1% NP-40, (ii) 1% NP40 plus either 0.25 M (NH4)2SO4 or 0.5 to 2.0 M NaCl, or (iii) RNase A. However, treatment with DNase I, which removes most of the DNA as judged by staining with Hoechst 33258 (data not shown), completely abolished detectable ND staining (Fig. 5C ). As a control, a sample treated identically with DNase I was also stained with an antibody that recognizes nuclear mitotic apparatus protein (NuMA), an abundant nuclear protein; NuMA staining was identical in DNase I-treated and untreated cells, indicating that DNase I treatment is not causing general proteolysis or complete loss of nuclear structure (data not shown). These experiments indicate that the ND protein is directly or indirectly associated with the nuclear DNA and that this association does not depend on membrane integrity. These results further suggest that the ND protein is tightly bound to the nucleus as it is not readily extracted with high concentrations of salt.
The ND protein can activate transcription in S. cerevisiae. Szostecki et al. reported similarities between amino acids 360 to 409 of the ND protein and some viral transcription factors (50) . The association of the ND protein with DNA and the sequence similarity suggested that the ND protein might be capable of activating transcription. We first tested this possibility in S. cerevisiae, because many mammalian transcriptional activators function properly in S. cerevisiae (25) . Full-length ND sequences were fused to the LexA DNA binding domain (codons 1 to 87). The resulting construct and a control plasmid lacking ND sequences were used to transform a yeast strain containing a LexA protein binding site upstream of a lacZ reporter gene (see Materials and Methods). Transcriptional activation for the yeast transformants was evaluated by determining 3-galactosidase activities by a plate blue color assay and quantitative liquid 1-galactosidase assay. As shown in Fig. 6 , the construct which carries a full-length ND protein sequence has a 14-fold increase of activity compared with the background control.
To determine the region responsible for transcriptional activation in S. cerevisiae, a series of constructs containing different portions of the ND coding regions were fused to lexA. Constructs containing sequences that encode amino acid residues 333 to 407 yield significant activation of transcription over background. In fact, a construct encoding only residues 333 to 407 exhibited the highest transcription activity; yeast strains with this construct had a 36-fold higher level of 1-Gal activity than did transformants with the vector alone. Thus, we conclude that the ND protein can serve to activate transcription in S. cerevisiae and the transcriptional activation domain resides in an -75-amino-acid segment.
The ND protein weakly activates transcription in mammalian cells. We also tested whether the ND protein can activate transcription in mammalian cells with the expression system (53) illustrated in Fig. 7 . DNA fragments encoding the full-length ND protein or the residue 333 to 407 region of the ND protein which activated transcription in S. cerevisiae were fused to the GAL4 DNA binding domain in vector pSG424. The constructs were cotransfected into CV1 cells with plasmid G5EC which contains GAL4 protein binding sites upstream of the CAT gene. The results from CAT assays are shown in Fig. 8 . The construct containing the ND transcription activation domain (residues 333 to 407) resulted in expression of the CAT gene in the CV1 cells, while either vector alone did not activate transcription ( Fig.  8 ; larger amounts of vectors [up to 15 ,ug] were also tested [data not shown]). The full-length ND construct did not activate transcription in these cells. Possible explanations for this result are provided in Discussion.
The amino acid sequence of the transcription activation domain (residues 330 to 410) was used to search the protein A. data base. Similar to what was reported by Szostecki et al. (50) , a number of sequence similarities with known transcription activators were found throughout this region ( Fig.  9 ).
DISCUSSION
The ND domain and antigen. In this report, we describe seven serum samples that recognize ND antigens. Consistent with the independent results of Ascoli and Maul (2) , the ND domains do not correspond to the nucleolus, kinetochores, or splicing centers. The ND antigens are also distinct in both molecular weight and subnuclear distribution from the polymorphic interphase karyosomal association antigens (42) . The NDs do not correspond to coiled bodies; double scence experiments with the rabbit polyclonal sera recognize a 72-kDa polypeptide which miuman anti-p80 coilin antibodies re-grates identically to that produced by overexpression of the ots and NDs do not colocalize (42a) .
cloned protein in E. coli. Although the basis of this anomathat the NDs compose a unique lous migration is not known, a variety of transcription Leus. Ascoli and Maul also presented factors that migrate significantly more slowly in SDS gels t the ND domains were often found in than expected have been described (11, 19, 44, 48, 55 ), a used in our studies clearly recognize indicating that this property is not unique to the ND protein. ain, we found no evidence of paired
The mobility observed in our immunoblot experiments is lines. It is likely that the differences different from that reported for the same ND antigens esent variations in the nuclear distriidentified by Szostecki et al. (100 kDa [50] ) and either the cell lines. same or another antigen identified by Ascoli and Maul (55 g the cloned ND antigen predicts a kDa [2] ). Szostecki et al. demonstrated that in vitro tranrof 53,000. Immunoblot experiments scription and translation of the same coding sequences uman autoimmune sera and the rabbit which we employed produced a protein that migrated at 100 kDa. We speculate that all three of these proteins are the same and that they migrate at different rates depending upon the gel system used. It is also possible that the 55,000-Mr protein identified by Ascoli and Maul is a breakdown product of the larger form or is a different polypeptide. Y D H S A G N .A SG..SPPQTIKNE 4PYQIS.'PTSSRLANPGS Z"'. FIG. 9. Sequence similarities between the ND transcription activation domain (amino acids 345 to 403) and some known transcription factors in the transcription factor data base (1) . The shaded area represents the amino acid residues which are shared by the different protein sequences.
In addition to its association with DNA, several lines of evidence indicate that the ND protein may regulate transcription. First, a 75-amino-acid domain (residues 333 to 407) that activates transcription in both yeast and mammalian cells has been identified and mapped. Second, this region exhibits sequence similarity to other transcriptional activators (31) (Fig. 9 ). The activating sequence of the ND protein is encoded in all of the ND cDNAs, suggesting that each of the putative ND protein isoforms contains this domain.
The ND fragment encompassing amino acid residues 333 to 407 exhibits higher transcription activation than the fulllength sequence of ND. Further analysis indicated that the sequence upstream of residues 333 to 407 can partially suppress the transcription activation of ND protein. Either the ND antigen may contain a negative regulatory domain(s) or the context of the activation domain in these hybrid protein systems may affect their efficiency in transcription activation. Context effects for these types of assays have been noted for other well-characterized transcription activators (e.g., AP1 [55a] ). It is also possible that the yeast and CV1 cell lines do not express the relevant factors that allow maximal transcription in these cells.
It is possible that the ND protein does not normally activate transcription in vivo and that it simply contains a domain which serendipitously possesses an activation function. However, we feel this is unlikely given its nuclear location and association with DNA. Our data are consistent with the hypothesis that the ND domains represent specific sites of transcription. We speculate that this ND protein is associated with a specific segment of the genome. It may serve as a transcriptional regulator of a discrete set of genes or a repetitive gene whose copies are clustered at a few locations. This hypothesis can be tested in future studies.
